The effectiveness of motor and psychiatric symptoms for Parkinson's disease patients by switching from Dopamine agonist to Zonisamide or combining Dopamine agonist and Zonisamide.
Phase of Trial: Phase III
Latest Information Update: 26 Jul 2017
At a glance
- Drugs Zonisamide (Primary) ; Dopamine
- Indications Parkinson's disease
- Focus Therapeutic Use
- 14 Dec 2016 Status changed from not yet recruiting to recruiting.
- 18 Nov 2016 New trial record